Study of emotional health in gender care clients
Part of Infections clinical trials.
This study looks at the thoughts, feelings, and social situations of people seeking gender-affirming care—like hormones or surgery—at a clinic in Thailand. It helps doctors better understand their needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 16 with a parent’s OK (if no surgery yet) or 18+.
- A counselor has recommended you based on your gender history and readiness.
- You understand the risks and benefits of gender-affirming hormones.
- You have social support and can take hormones as directed.
- A doctor has cleared you (no medical reasons to say no).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to reduce HIV stigma and improve PrEP use among young transgender women in Thailand. It is testing a new program to help those who are not already taking PrEP consistently.
This study tests a new support program designed specifically for transgender people who use drugs or engage in chemsex (using drugs during sexual activity). The program aims to reduce health risks and provide safer, more culturally respectful care.
This study aims to develop healthcare services tailored to transgender people regarding chemsex (using drugs during sex). Researchers will interview participants to understand their needs and experiences.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
This study follows adults who are referred to a gender dysphoria assessment clinic in southern Sweden to see how gender-affirming care affects quality of life, work life, and overall health over time.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.